Navigation Links
AtheroNova Initiates Phase 1 Clinical Trial of AHRO-001, a Potential Treatment for Atherosclerosis
Date:6/25/2013

IRVINE, Calif., June 25, 2013 /PRNewswire/ -- AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces achievement of a major milestone with the initiation of a Phase 1 clinical trial with its lead compound, AHRO-001.  The Phase 1 study will evaluate the safety, tolerability and pharmacokinetics of AHRO-001 in healthy volunteers. The clinical study is being conducted in Russia with AtheroNova's licensing partner, OOO CardioNova.

"There is a significant unmet need for effective and well-tolerated agents in the treatment of both atherosclerosis and lipid modulation," said Thomas W. Gardner, Chairman and Chief Executive Officer of AtheroNova.  "Based on AHRO-001's preclinical profile, we believe it has the potential to offer patients effective treatment for these chronic conditions with an improved therapeutic profile.  We look forward to assessing AHRO-001 in human trials and are extremely pleased to have met a significant milestone with transitioning into a clinical stage company."

The Phase 1 study is a randomized, double-blind, placebo controlled study that assesses ascending doses of AHRO-001 in healthy adult volunteers.  The program advanced into Phase 1 clinical testing following extensive successful preclinical studies with AHRO-001.

"This is clearly an exciting and transformative time for us," remarked Mark K. Wedel, MD, Chief Medical Officer of AtheroNova.

About AHRO-001

AHRO-001 is AtheroNova's first novel application for the treatment and prevention of atherosclerosis. Atherosclerotic plaque is the primary, underlying cause of heart disease and stroke in industrialized countries. AtheroNova has shown positive results in animal models for regression of pl
'/>"/>

SOURCE AtheroNova Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AtheroNova Announces Milestone Filing of IND in Russian Federation
2. AtheroNova Receives Notice of Allowance for Its US Patent Application 12/024,908
3. AtheroNova Signs Agreement for Development of Clinical Trial Supplies
4. Xenon Licenses Antisense Drug XEN701 From Isis and Initiates Preclinical Toxicology Studies
5. Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients
6. AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
7. Soligenix Initiates Phase 1 Clinical Study with SGX203 for the Treatment of Pediatric Crohns Disease
8. Ambrx Initiates Collaboration with Bristol-Myers Squibb for Discovery, Development of Next-Generation Antibody Drug Conjugates
9. Acutus Medical, Inc. Initiates "First-In-Man" Clinical Study of Real-Time 3D Imaging Catheter with CT/MRI Quality
10. ISIS Pharmaceuticals Initiates a Clinical Study of ISIS-SMN Rx in Infants With Spinal Muscular Atrophy
11. Romark Laboratories Initiates Phase 3 Trial of New Influenza Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 2015  Uroplasty, Inc. (NASDAQ: UPI ), a ... proprietary products to treat voiding dysfunctions, today announced that ... on Tuesday, March 10, 2015. Rob Kill , ... Financial Officer, will present at 4:00 p.m. Pacific Time ... conference at the Ritz Carlton in Laguna ...
(Date:2/26/2015)... 2015 RnRMarketResearch.com adds Corneal ... report to its store. This report p provides ... The report "Corneal Ulcers - Pipeline Review, H2 ... for Corneal Ulcers. Corneal Ulcers are primarily result ... viral infections & fungal infections. The symptoms of ...
(Date:2/26/2015)... , Feb. 26, 2015  Mobility Ventures LLC, ... agreement with Bank of America (NYSE: BAC ... to receive financing of the revolutionary MV-1 - - ... from the ground up to provide safe and comfortable ... can use their loan to purchase a new MV-1 ...
Breaking Medicine Technology:Uroplasty to Participate in the 27th Annual ROTH Conference 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 2Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 3
... 2011 Inovio Pharmaceuticals, Inc. (NYSE Amex: ... and preventive vaccines against cancers and infectious diseases, announced ... partnering and scientific conferences: BioPartnering North ... corporate overview on Inovio at the 9th Annual BioPartnering ...
... Feb. 21, 2011 Acuo Technologies®, a market ... medical imaging industry for archiving, collaboration and migration ... Fiscal Year 2010. The company achieved 25% growth ... three-year compounded annual growth rate of 55% in ...
Cached Medicine Technology:Inovio Pharmaceuticals to Present at Partnering and Scientific Conferences 2Inovio Pharmaceuticals to Present at Partnering and Scientific Conferences 3Acuo Technologies Announces Another Significant Growth Year in Revenue and Implementations to Further the Company's Market Leading Position 2
(Date:2/28/2015)... St. Louis, MO (PRWEB) February 28, 2015 ... a leading provider of outsourced sales, marketing and ... announces their client, BIOTA Botanicals, is bringing its ... , Celebrated worldwide, BIOTA Botanicals’ products are specifically ... the herbal care experts, BIOTA is committed to ...
(Date:2/28/2015)... India Network Foundation, a US ... programs for visitors coming to the United States for ... to the United States are suffering from one or ... These diseases are so common among the elderly population ... conditions. There were 66.8 million cases of diabetes in ...
(Date:2/28/2015)... Kaylie Corrigan, Outdoor Supervisor at Back2Basics Outdoor ... student obtaining her Masters degree in social work at ... psychoeducation on substance use for teens at the local ... her studies. , “Even though these students are young, ... the high school and junior high school level,” said ...
(Date:2/28/2015)... On Thursday, February 26th, Forbes published an article titled ... Steal Your Data , which stresses the ease with which ... phishing kit, or any kind of malware kit for that ... about how everyone’s cyber security is intertwined when it covers ... content management systems or blogs in order to install the ...
(Date:2/28/2015)... The noted Toronto plastic surgeon Dr. David ... featured in the January/February 2015 issue of Elevate magazine. ... was featured in an article entitled “Get the Look: ... Kim Cattrall has possibly undergone to maintain her youthful ... without horizontal lines or frown line creases, which can ...
Breaking Medicine News(10 mins):Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 3Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 3Health News:Staff at Arizona Drug Addiction Treatment Center Starts Teen Sobriety Support Group at Local High School 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 4Health News:Dr. David Ellis Featured In Elevate Magazine 2
... Conn. Yale scientists have discovered the molecular pathway ... DNA mutations trigger a signaling cascade, resulting in programmed ... issue of Cell . Mitochondria are cellular ... generate most of the cell,s supply of energy. They ...
... HealthDay Reporter , THURSDAY, Feb. 16 (HealthDay News) ... anymore. In a new small study, women with severe ... drugs at the push of a button, a delivery ... conditions. Roughly 1.5-by-2.5 inches in size, the microchip ...
... patients with septic shock is safe and decreases vasopressor ... from researchers in France. "The benefits and ... remains a matter of controversy," said lead author Frdrique ... Crteil, France. "In our study, external cooling to achieve ...
... Montaner of the British Columbia Centre for Excellence in ... in this week,s PLoS Medicine that the cost-effectiveness of ... analyses have not yet taken into account the beneficial ... The authors comment: "the strategic value of expanded ...
... -- Most men who have surgery for prostate cancer can ... gland are not removed, according to a new study. ... number of his nerves that are spared will play a ... study followed 408 men who underwent a procedure to remove ...
... and grading, schoolteachers have a demanding job, and lately it,s ... challenges, thousands of Florida educators rely on a free, online ... teaching tools and resources, just when they need them. Soon ... Department of Education using federal Race to the Top funds ...
Cached Medicine News:Health News:How mitochondrial DNA defects cause inherited deafness 2Health News:Implanted Microchip Might Be Future of Drug Delivery 2Health News:Implanted Microchip Might Be Future of Drug Delivery 3Health News:Fever control using external cooling reduces early mortality in septic shock patients 2Health News: Nerve-Sparing Prostate Surgery Helps Men Retain Sexual Function 2Health News:$10.5 million grant will expand vast online hub for educators, by educators 2Health News:$10.5 million grant will expand vast online hub for educators, by educators 3Health News:$10.5 million grant will expand vast online hub for educators, by educators 4
ThyroTest TSH is a rapid, qualitative test for hypothyroidism screening in adults....
... is an ultra-high speed, high resolution optical ... retina imaging and analysis. It ... Optical Coherence technology just emerging from clinical ... The ultra-high speed and high resolution ...
... finest surgical-quality loupes available at ... for innovative optical design, combining superior ... optimum performance with maximum comfort, SheerVision ... medical professionals worldwide. All SheerVision loupes ...
... the finest surgical-quality loupes available ... standard for innovative optical design, combining ... Delivering optimum performance with maximum comfort, ... for medical professionals worldwide. All SheerVision ...
Medicine Products: